i think management should take a breather. Rather than going to test cvac on other cancers the same way testing was done with OC, management should investigate what treatment (apart from chemo) can work in synergy with cvac. Perhaps look at how Gradalis is applying FANG to OC. A phone call to Dr French of Benitec can be rewarding as to how gene silencing can help to weaken cancer cells, thereby improving the potency of cvac.My thoughts.
i think management should take a breather. Rather than going to...
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
28.5¢ |
Change
-0.010(3.39%) |
Mkt cap ! $421.2M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 30.0¢ | 28.5¢ | $939.3K | 3.234M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 26 | 336331 | 28.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.0¢ | 225814 | 35 |
View Market Depth
| Last trade - 12.47pm 06/08/2024 (20 minute delay) ? |
| IMM (ASX) Chart |